Establishment of quantitative scale for long COVID stigma estimation among UK residents SussexUni LongCOVID COVID19 SARSCoV2 UK Stigma
By Pooja Toshniwal PahariaNov 28 2022Reviewed by Aimee Molineux In a recent study published in PLoS ONE, researchers developed and validated the long coronavirus disease stigma scale to quantify the burden of long COVID stigma in the United Kingdom .
About the study In the present study, researchers developed and validated the LCSS scale for quantitatively estimating the stigma associated with long COVID based on follow-up online survey data of individuals living with long COVID in the UK. Questions were designed to obtain data on demographic parameters, work capabilities, the status of employment, disease patterns and their health impacts, persistent COVID 2019 symptoms, clinically diagnosed long COVID or other medical conditions, COVID-19 vaccinations, and stigma experiences. The survey included only adults with suspected or confirmed COVID-19 who were not hospitalized in the initial 14 days of developing symptoms and those who completed baseline surveys in November 2021.
Results In total, 1166 individuals filled out follow-up surveys on long COVID stigma, 966 of which were UK residents, and 888 answered the LCSS survey questions. The average age of the participants was 48 years, and 85% of them were female. Most of the respondents lived in England, Scotland, Wales, and North Ireland, and 76% of the survey respondents had attained at least university-level education.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery - Molecular BiomedicinePeople with acute COVID-19 due to SARS-CoV-2 infection experience a range of symptoms, but major factors contributing to severe clinical outcomes remain to be understood. Emerging evidence suggests associations between the gut microbiome and the severity and progression of COVID-19. To better understand the host-microbiota interactions in acute COVID-19, we characterized the intestinal microbiome of patients with active SARS-CoV-2 infection in comparison to recovered patients and uninfected healthy controls. We performed 16S rRNA sequencing of stool samples collected between May 2020 and January 2021 from 20 COVID-19-positive patients, 20 COVID-19-recovered subjects and 20 healthy controls. COVID-19-positive patients had altered microbiome community characteristics compared to the recovered and control subjects, as assessed by both α- and β-diversity differences. In COVID-19-positive patients, we observed depletion of Bacteroidaceae, Ruminococcaceae, and Lachnospiraceae, as well as decreased relative abundances of the genera Faecalibacterium, Adlercreutzia, and the Eubacterium brachy group. The enrichment of Prevotellaceae with COVID-19 infection continued after viral clearance; antibiotic use induced further gut microbiota perturbations in COVID-19-positive patients. In conclusion, we present evidence that acute COVID-19 induces gut microbiota dysbiosis with depletion of particular populations of commensal bacteria, a phenomenon heightened by antibiotic exposure, but the general effects do not persist post-recovery.
Consulte Mais informação »
China protests turn violent as zero-Covid anger spreads\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Consulte Mais informação »
Covid protests widen in China after Urumqi fireVideos on social media appear to show some protesters asking leader Xi Jinping to resign.
Consulte Mais informação »
Rare protests in China as fatal fire collides with zero-COVID fatigueChina is the only major country still fighting COVID with lockdowns and mass testing but, after living with extreme restrictions for months, many citizens have had enough.
Consulte Mais informação »
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial - BMC MedicineBackground Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone treatment on patients with persistent olfactory disorders after COVID-19. Methods We performed a randomized, double-blind, placebo-controlled, single-centered trial in the Netherlands. Patients were included if they were | 18 years old and if they had persistent (| 4 weeks) olfactory disorders within 12 weeks after a confirmed COVID-19 test. The treatment group received oral prednisolone 40 mg once daily for 10 days and the placebo group received matching placebo. In addition, all patients performed olfactory training. The primary outcome was the objective olfactory function on Sniffin’ Sticks Test (SST) 12 weeks after the start of treatment, measured in Threshold-Discrimination-Identification (TDI) score. Secondary outcomes were objective gustatory function assessed by the Taste Strip Test (TST) and subjective self-reported outcomes on questionnaires about olfactory, gustatory and trigeminal function, quality of life, and nasal symptoms. The CONSORT 2010 guideline was performed. Results Between November 2021 and February 2022, we included 115 eligible patients, randomly assigned to the treatment (n = 58) or placebo group (n = 57). No difference in olfactory function between groups was obtained after 12 weeks. Median TDI score on SST was 26.8 (IQR 23.6–29.3) in the placebo group and 28.8 (IQR 24.0–30.9) in the prednisolone group, with a median difference of 2.0 (95% CI 0.75 to 1.5). There was similar improvement on olfactory function in both groups after 12 weeks. Furthermore, on secondary outcomes, we obtained no differences between groups. Conclusions This trial shows that prednisolone does not improve olfactory function after COVID-19. Therefore, we recommend not prescribing prednisolone for patients with persistent olfactory disorders after COVID-19. Trial registration Thi
Consulte Mais informação »
Strictly address Kym Marsh's absence from show after testing positive for CovidKym Marsh is sadly absent from tonight's Strictly Come Dancing after testing positive for Covid-19, with the show's team wishing her well at the start of the show
Consulte Mais informação »